Evidence map›Paper›PMID 27625063›Full record

ArticleBMJ open2016

Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers.

Timothy Kubal, Doug G Letson, Alberto A Chiappori, Gregory M Springett, Riti Shimkhada, Diana Tamondong Lachica, John W Peabody

Abstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Timothy KubalMoffitt Cancer Center, Tampa, Florida, USA.
Doug G LetsonMoffitt Cancer Center, Tampa, Florida, USA.
Alberto A ChiapporiMoffitt Cancer Center, Tampa, Florida, USA.
Gregory M SpringettMoffitt Cancer Center, Tampa, Florida, USA University of South Florida, College of Medicine, Tampa, Florida, USA.
Riti ShimkhadaQURE Healthcare, San Francisco, California, USA.ORCID 0000-0002-5177-4853
Diana Tamondong LachicaQURE Healthcare, San Francisco, California, USA.
John W PeabodyQURE Healthcare, San Francisco, California, USA University of California, San Francisco California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study examined whether a measurement and feedback system led to improvements in adherence to clinical pathways.

designThe M-QURE (Moffitt-Quality, Understanding, Research and Evidence) Initiative was introduced in 2012 to enhance and improve adherence to pathways at Moffitt Cancer Center (MCC) in three broad clinical areas: breast, lung and gastrointestinal (GI) cancers. M-QURE used simulated patient vignettes based on MCC's Clinical Pathways to benchmark clinician adherence and monitor change over three rounds of implementation.

settingMCC, located in Tampa, Florida, a National Cancer Institute Comprehensive Cancer Center.

participantsThree non-overlapping cohorts at MCC (one each in breast, lung and GI) totalling 48 providers participated in this study, with each member of the multidisciplinary team (composed of medical oncologists, radiation oncologists, surgeons and advanced practice providers) invited to participate.

interventionsEach participant was asked to complete a set of simulated patient vignettes over three rounds within their own cancer specialty. Participants were required to complete all assigned vignettes over each of the three rounds, or they would be excluded from this study. PRIMARY OUTCOME MEASURE: Increased domain and overall provider care adherence to clinical pathways, as scored by blinded physician abstractors.

resultsWe found significant improvements in pathway adherence between the third and first rounds of data collection particularly for workup and treatment of cancer cases. By clinical grouping, breast improved by 13.6% (p<0.001), and lung improved by 12.1% (p<0.001) over baseline, whereas GI showed a decrease of 1.4% (p=0.68).

conclusionsClinical pathway adherence improved in a short timeframe for breast and lung cancers using group-level measurement and individual feedback. This suggests that a measurement and feedback programme may be a useful tool to improve clinical pathway adherence.

Indexed as

Disease ManagementFeedbackAdultBreast NeoplasmsCritical PathwaysFemaleFloridaGastrointestinal NeoplasmsGuideline AdherenceHumansLinear ModelsLongitudinal StudiesLung NeoplasmsMaleMiddle AgedSeverity of Illness IndexMEDICAL EDUCATION & TRAININGONCOLOGY

Identifiers

PMID27625063
PMCPMC5030551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.